Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration
2017; American Medical Association; Volume: 318; Issue: 4 Linguagem: Inglês
10.1001/jama.2017.7704
ISSN1538-3598
AutoresRita F. Redberg, Alison Jacoby, Joshua M. Sharfstein,
Tópico(s)Healthcare cost, quality, practices
ResumoThis Viewpoint uses the example of power morcellator devices to discuss the wider scope of US Food and Drug Administration regulations and postmarketing surveillance necessary to ensure patient safety.
Referência(s)